Search clinical trials for: Angiotensin-Converting Enzyme Inhibitors

Total 47041 results

Boehringer Ingelheim

Completed

Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension

Hypertension

United States, Argentina, Canada, Chile, Mexico, Peru
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Ramipril

Obesity, Morbid

Norway
Institut de Recherches Internationales Servier

Completed

S90652 in Paediatric Hypertension

Hypertension

France
Daniel Carradice

Completed

Clinical and Cost Effectiveness of ACE Inhibitor, Ramipril, in Intermittent Claudicants

Intermittent Claudicants

United Kingdom
Seoul National University Hospital

Completed

An Open-labeled Trial of Ramipril in Patients With Migraine

Migraine With Hypertension

Korea, Republic of
Chinese University of Hong Kong

Completed

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial

Normal Blood Pressure | Biopsy-confirmed IgA Nephropathy | Proteinuria Less Than 0.5 g Per Day | Serum Creatinine Below 120 Umol/l

Hong Kong
Sanofi

Completed

Ramipril 10 mg/Day Prevention

Atherosclerosis

Bangladesh
The Hospital for Sick Children

Unknown

Rapid Versus Prolonged Inpatient Up-Titration of Captopril

Heart Disease

Canada
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation

Coronary Disease | Atherosclerosis | Vasculitis

United States
Montreal Heart Institute
Pfizer

Completed

Management With Accupril Post Bypass Graft

CABG
Case Comprehensive Cancer Center

Withdrawn

Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms

Myeloproliferative Neoplasm | Bone Marrow Fibrosis

United States
Aristotle University Of Thessaloniki

Completed

Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes Mellitus

Diabetic Autonomic Neuropathy
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Studies of Left Ventricular Dysfunction (SOLVD)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Heart Failure | Coronary Disease | Hypertension
National Cheng-Kung University Hospital

Unknown

Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in Human

Heart Failure

Taiwan
University of Pavia

Unknown

Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria

Hypertension | Type 2 Diabetes

Italy
Gulhane School of Medicine

Completed

The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria

Diabetes | Proteinuria | Renin Angiotensin System

Turkey
National Center for Research Resources (NCRR)
Stanford University

Completed

Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy

IGA Glomerulonephritis
Sherief Abd-Elsalam

Recruiting

Effect of Some Drugs on Liver Fibrosis

Liver Fibroses

Egypt
Brigham and Women's Hospital

Completed

Replication of the ONTARGET Antihypertensive Trial in Healthcare Claims Data

Hypertension

United States
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Preventing ESRD in Overt Nephropathy of Type 2 Diabetes (VALID)

Diabetes

Italy, Slovenia
Yonsei University

Completed

Precision Treatment With Angiotensin Converting Enzyme Inhibitor

Hypertension

Korea, Republic of
Hospital Clínico Universitario de Valladolid

Active, not recruiting

Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI) (RASTAVI)

Angiotensin-Converting Enzyme Inhibitors | Transcatheter Aortic Valve Replacemen

Spain
Roxane Laboratories

Completed

Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions

Hypertension

United States
Gene PreDiT
Blueclinical, Ltd.

Terminated

Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects (GPD-01-01)

Obesity

Portugal
InCor Heart Institute
University of Sao Paulo; Federal University of Minas Gerais

Completed

Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial

Myocardial Fibrosis | Muscular Dystrophies
Gulhane School of Medicine

Completed

FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients

Diabetic Nephropathy | Proteinuria | Chronic Kidney Disease

Turkey
Sanofi

Completed

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

Glomerulonephritis

Hong Kong
University of Zurich
Sanofi

Completed

Ramipril in Rheumatoid Arthritis

Arthritis, Rheumatoid
Sunnybrook Health Sciences Centre
Alzheimer's Drug Discovery Foundation; Weston Brain Institute

Recruiting

Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients (SARTAN-AD)

Alzheimer's Disease

Canada
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Remission Clinic in Proteinuric Chronic Nephropathies

Chronic Kidney Disease

Italy
Catholic University of the Sacred Heart

Unknown

Telmisartan Versus Ramipril After Acute Coronary Syndrome (TERACS)

Myocardial Infarction | Coronary Disease | Acute Coronary Syndrome

Italy
Southern Medical University, China

Terminated

Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency

Disease Progression | Proteinuria | Renal Insufficiency,Chronic | Dose-Response Relationship,Drug | ACE Inhibitor | Angiotensin II Type 1 Receptor Blockers

China
Northwestern University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile...

Terminated

PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease) (PREVENTKD)

Type 1 Diabetes

United States
University of Nebraska

Recruiting

Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis

Peripheral Arterial Disease

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Terminated

Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy

Lung Cancer | Pulmonary Complications | Radiation Fibrosis

United States
Wake Forest University

Completed

Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart Failure (PIE-I)

Heart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
Novartis Pharmaceuticals

Completed

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Hypertension

United States, Hungary, Turkey, Guatemala, Slovakia, Puerto Rico, Poland
Novartis

Completed

Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg

Hypertension

China, India, Thailand
Gulhane School of Medicine

Completed

Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria

Diabetic Nephropathy | Proteinuria | Chronic Kidney Disease

Turkey
Baker Heart Research Institute

Completed

The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Boehringer Ingelheim

Completed

DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

Hypertension | Diabetes Mellitus, Type 2

United Kingdom, Denmark, Finland, Netherlands, Norway, Sweden
Novartis

Completed

A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Institut de Recherches Cliniques de Montreal

Terminated

Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes

Hypertension | Type 2 Diabetes | Albuminuria

Canada
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Preventing Microalbuminuria in Type 2 Diabetes (VARIETY)

Diabetes

Italy
Xinhua Hospital, Shanghai Jiao Tong University...

Not yet recruiting

Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants

Alport Syndrome

China
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Enalapril

Obesity, Morbid

Norway
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Active, not recruiting

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Glioblastoma | Chemoradiation | Cognitive Decline | Radiotherapy; Complications

United States, Guam
Sanofi

Completed

An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event (HOPETips)

Coronary Artery Disease

Indonesia
Ain Shams University

Completed

Ramipril in Pediatric Patients on Hemodialysis

Hemodialysis

Egypt
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure (ATMOSPHERE)

Chronic Heart Failure

China, United States, Belgium, Colombia, India, Korea, Republic of, Poland, Romania, Italy, Spain, Austria, Estonia, France, Germany, Japan, Taiwan, Turkey, Netherlands, Sweden, Switzerland, United Kingdom, Thailand, Australia, Ireland, Russian Federation and more

Search clinical trials for: Angiotensin-Converting Enzyme Inhibitors

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations